SEC Company Response from CBD Life Sciences Inc. (CBDL) (CIK 0001776073) (CBDL) — Mar 6, 2020
CBD Life Sciences Inc. (CBDL) (CIK 0001776073)
Date: March 6, 2020 · CIK: 0001776073 · Accession: 0001683168-20-000707
AI Filing Summary & Sentiment
Reasoning
Letter
Securities and Exchange Commission 100 F Street NE Washington, DC 20549 Re: CBD Life Sciences Inc. CIK: 0001776073
Dear Sir/Madam:
Kindly be advised that CBD Life Sciences Inc., (the "Company") requests that its Regulation A offering be qualified on Wednesday, March 11, 2020 at 12 noon.
The State of New York has registered us.
If you would like any further information or have any questions, please do not hesitate to contact me at (480) 410-6780.
Sincerely,
/s/ Lisa Nelson
Show Raw Text
CORRESP
1
filename1.htm
Lisa Nelson
CBD Life Sciences Inc.
10855 N. 116th Street
Suite 115
Scottsdale, AZ 85259
(480) 410-6780
March 06, 2020
Securities and Exchange Commission
100 F Street NE
Washington, DC 20549
Re:
CBD Life Sciences Inc.
CIK: 0001776073
Dear Sir/Madam:
Kindly be advised that CBD Life Sciences Inc., (the "Company")
requests that its Regulation A offering be qualified on Wednesday, March 11, 2020 at 12 noon.
The State of New York has registered us.
If you would like any further information or have
any questions, please do not hesitate to contact me at (480) 410-6780.
Sincerely,
/s/ Lisa Nelson
Lisa Nelson
Chief Executive Officer